NCT00402454View on ClinicalTrials.gov

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 31, 1994

Study Completion Date

December 31, 1998

Conditions

HIV Infections

Interventions

DRUG

isoniazid, rifampin + isoniazid or rifampin + pyrazinamide

Trial Locations (1)

14002

Hospital Universitario Reina Sofía, Córdoba

All Listed Sponsors

lead

Sociedad Andaluza de Enfermedades Infecciosas

NETWORK

NCT00402454 - Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis | Biotech Hunter | Biotech Hunter